Weekly Administration of Brodalumab in Hidradenitis Suppurativa: An Open Label Cohort Study
Published: 20-06-2020| Version 2 | DOI: 10.17632/s3x24k6dky.2
Contributor:
John Frew
Description
Clinical Trial of Weekly Brodalumab in Hidradenitis Suppurativa